Noventra Pharma SLU-PP-332 (2mg Mitochondrial Enhancing Peptide – 2ml Multi Dose Pen)

SLU?PP?332 by Noventra Pharma is a next-generation metabolic compound designed to support mitochondrial function, energy production, and endurance capacity. It is commonly classified as an exercise-mimetic compound, meaning it activates cellular pathways similar to those stimulated during physical exercise. At a molecular level, SLU?PP?332 functions as an estrogen-related receptor (ERR) agonist, influencing pathways involved in energy metabolism, fatty acid oxidation, and mitochondrial activity. These mechanisms are associated with increased cellular energy output, improved metabolic efficiency, and enhanced endurance performance. Preclinical research has demonstrated that compounds in this class may increase energy expenditure, improve mitochondrial respiration, and support fat metabolism without requiring increased physical activity, highlighting its potential role in metabolic optimisation strategies. SLU?PP?332 is commonly positioned within performance, endurance, and metabolic health protocols, particularly for individuals seeking improved energy utilisation, enhanced stamina, and more efficient fat oxidation. The multi-dose pen format allows for precise, consistent administration within structured routines. Key Features: - 2mg SLU?PP?332 mitochondrial-enhancing compound - Exercise-mimetic mechanism activating metabolic pathways - Supports mitochondrial function and cellular energy production - Promotes fatty acid oxidation and metabolic efficiency - Associated with improved endurance and stamina - May support energy expenditure and body composition - Multi-dose pen for accurate and convenient dosing Suggested Use: Typically administered in controlled doses as part of a structured protocol. Frequency and dosing may vary depending on individual goals and should be guided by a qualified healthcare provider. Storage: Refrigerate at 2–8°C. Protect from light. Do not freeze. Important Information: This product is intended for research or medical use under professional supervision only. SLU?PP?332 is an experimental compound with limited human clinical data available. Potential effects are based primarily on preclinical research, and long-term safety has not yet been fully established. Always consult a qualified healthcare provider before use.